Medical Cannabis is Driving Market Expansion

Medical Cannabis’ Burgeoning Reputation is a Boon for the Market’s Expansion

NEW YORKFeb. 26, 2021 /PRNewswire/ — The cannabis industry has drastically changed over the course of the last five years. Thanks to shifting consumer sentiments, legislative victories across several major states, and the availability of new products for a wide demographic, the cannabis industry has become a major market attracting investors from all over the world. Slowly, more and more states are implementing legislating to regulate such products. For example, New Jersey voters legalized an adult-use marijuana market last year. This week Gov. Phil Murphy finally delivered on a 2017 campaign promise, signing legislation that legalizes cannabis for adults, decriminalizes the possession of up to six ounces of the drug, and codifies criminal justice reforms that will upend how police officers interact with underage offenders. However, some obstacles remain, and according to a report by Politico, the newly-formed Cannabis Regulatory Commission has been tasked with overseeing both the adult-use and medical marijuana markets and developing rules that will dictate the distribution of dispensary and cultivation licenses. Red White & Bloom Brands Inc. (CSE: RWB) (OTC: RWBYF), Sundial Growers Inc. (NASDAQ: SNDL), Aurora Cannabis Inc. (NYSE: ACB), Acreage Holdings Inc. (OTC: ACRHF), Canopy Growth Corporation (NASDAQ: CGC)

Currently, the medical cannabis sector accounts for the majority of the market share. Additionally, progress is slowly being made in removing the stigmas associated with such products. Medical cannabis is predominantly being used to alleviate symptoms associated with afflictions such as chronic pain, cancer, and epilepsy. Positive data has even led many U.S. states to legalize medical cannabis, as CBD products, in particular, have become more popular and well-known due to their lack of psychoactive effects many associates with cannabis. For example, in a HelloMD and Brightfield Group survey, approximately 60% out of 2,400 patients said that CBD participants used the compound to treat insomnia or other sleep problems successfully. Meanwhile, 42% of CBD users stopped using traditional medications and now use cannabis instead, and 80% of CBD users found CBD to be very or extremely effective for treatment.

Red White & Bloom Brands Inc. (CSE: RWB) (OTC: RWBYF) announced yesterday breaking news that “it has entered into a definitive agreement with HSCP, LLC (the seller” a subsidiary of Acreage Holdings Inc. (“Acreage”) (CSE: ACRG.A.U, ACRG.B.U) (OTCQX: ACRDF, ACRHF), pursuant to which a newly incorporated subsidiary of the Company, RWB Florida LLC will purchase all of the issued and outstanding shares of common stock of Acreage Florida, Inc. (“Acreage Florida”) from the Seller. The Company will also acquire certain owned and leased real estate assets used in Acreage Florida’s operations.

Acreage Florida is licensed to operate medical marijuana dispensaries, a processing facility, and a cultivation facility in the state of Florida. The deal also includes the sale of property in Sanderson, Florida, that includes over 15 acres of land and has a 113,546 SF facility for cultivation and a 4,360 SF freestanding administrative office building. In addition, Acreage Florida has 8 leased stores in prime locations throughout the state.

RWB intends to introduce its award-winning Platinum Vape brands immediately and leverage the previously announced rights to High Times® branded products at both the RWB store level and throughout the State of Florida following the closing of this acquisition.

Brad Rogers, Chief Executive Officer of RWB, stated, “Our core strategy has always been to focus on a limited number of markets within which to operate at scale, and Florida has always been one of those targeted markets. Today we have our path to entry into the third-largest market by revenue in the US and are excited with what we can do with the brands we have amassed as well as the skill to execute on our vision.”

When coupled with the Company’s recently announced acquisition in Illinois, this transaction further expands the Company’s representation in States with limited cannabis licenses. Upon closing existing definitive agreements, RWB will have a presence through licensed operations and/or the licensing of its brands in 6 States…

About Red White & Bloom Brands Inc.: The Company is positioning itself to be one of the top three multi-state cannabis operators active in the U.S. legal cannabis and hemp sector. RWB is predominantly focusing its investments on the major US markets, including FloridaIllinoisCaliforniaMichiganOklahoma and Arizona with respect to cannabis, and the US and internationally for hemp-based CBD products.”

For our latest “Buzz on the Street” Show featuring Red White & Bloom Brands Inc., recent corporate news, please head over

Last month, Sundial Growers Inc. (NASDAQ: SNDL) reported that it had launched high-quality cannabis derivative products under the Top Leaf brand in response to rising consumer demands for solventless cannabis extracts. This most recent launch is consistent with Sundial’s focus on premium inhalable, following branded retail offerings of flower, pre-roll, and vape cartridges. “We made a strategic decision to produce these premium products based on demand for solventless, flavorful, pure, and potent cannabis concentrates from a growing group of consumers,” said Andrew Stordeur, President and Chief Operating Officer of Sundial. “Our control of the entire manufacturing process from cultivation to extraction enables us to deliver premium quality products consistently. Adding bubble hash and other advanced concentrates to our product portfolio will expand Sundial’s share of this rapidly expanding market segment.”

Aurora Cannabis Inc. (NYSE: ACB) announced in November that it has entered into a strategic Supply Agreement with Cantek Holdings, one of Israel’s leaders in the medical cannabis field. Under the terms of the Agreement, Aurora will supply Cantek with dried bulk flower over a two-year period, with the option to extend. The Company intends to provide Cantek with a minimum of 4,000 kgs of bulk dried flower annually, which will be processed into a finished product and co-branded under the Aurora and Cantek brand names for the Israeli market potential for additional international market sales. “We are excited about our strategic relationship with Cantek, a leader in the Israeli market. This Agreement provides Aurora with a great opportunity to expand our medical cannabis brand and industry-leading science in one of our key international markets of focus,” said Miguel Martin, Chief Executive Officer of Aurora. “Today’s announcement demonstrates more than just a supply agreement. It’s about the strength and quality of the Aurora medical brand being validated once again by the world’s medical cannabis markets, including countries like Israel. We had no distribution before today. We consider this Agreement to be a significant step for Aurora, and we look forward to bringing our high-quality medical cannabis products to patients in Israel.”

Acreage Holdings Inc. (OTCQX: ACRHF) and Canopy Growth Corporation reported earlier last year that following the implementation of their amended arrangement, Acreage has developed a plan to market Canopy Growth’s diverse beverage portfolio in the United States. Leading with legal adult-use markets in Illinois and California, Acreage anticipates launching Canopy Growth’s select, sessionable THC beverage formulations in summer 2021. In addition to selling products in its own dispensaries, Acreage will access existing distribution channels through strategic corporate relationships. “We have had an incredibly successful introduction into the Canadian cannabis-infused beverage industry with over 1.7 million cans of our THC-infused RTD beverages, like Tweed’s Houndstooth & Soda and Bakerstreet & Ginger sold to date,” shared Canopy Growth CEO David Klein. “We introduced a new product category to cannabis consumers that we knew had the potential to disrupt one of the most mature industries, and since launching in Canada, Canopy Growth now owns 5 of the top 6 SKUs in the beverage category with a 74% market share. We are excited for Canopy’s beverages to be introduced to the U.S. market next summer.”

Canopy Growth Corporation (NASDAQ: CGC) announced this week that it had closed the previously announced plan of arrangement under the Business Corporations Act (Ontario) (the “Arrangement”) involving Canopy Growth, RIV Capital Inc. (formerly Canopy Rivers Inc.) (“RIV Capital”) (TSX: RIV) (OTC: CNPOF) and its wholly-owned subsidiary, RIV Capital Corporation (formerly Canopy Rivers Corporation) (“RCC”), as well as Canopy Growth’s wholly-owned subsidiary, The Tweed Tree Lot Inc. (“Tweed NB”). “Our conditional ownership in TerrAscend is a key component of our U.S. ecosystem strategy and strengthens our U.S. exposure ahead of the promising cannabis reform in the U.S.,” said David Klein, Chief Executive Officer of Canopy Growth. “Also, the divestiture of our interest in RIV Capital allows Canopy Growth to improve our focus as an organization further.”

About, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis, and Company Interviews. A pioneer in the financially driven digital space, video production, and social media integration, creates 100% unique original content. also provides financial news PR dissemination, branding, marketing, and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: is not a financial advisory or advisor, investment advisor, or broker-dealer and does not undertake any activities that would require such registration. The information provided on (the ‘Site’) is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content),, a financial news media, and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. has not been compensated directly by any of the companies mentioned here in this editorial unless mentioned otherwise. We are not an independent news media provider and therefore do not represent or warrant that the Site’s information is accurate, unbiased, or complete. receives fees for producing and presenting high-quality and sophisticated content on along with other financial news PR media services. does not offer any personal opinions, recommendations, or bias commentary as we purely incorporate public market information along with financial and corporate news. only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For red white & bloom brands inc. video production, filming editing, news reporting, financial and corporate news dissemination, has been compensated five thousand dollars by 1830012 Ontario Ltd. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement, and the balance is paid on or near the conclusion of the engagement. will always disclose any compensation in securities or cash payments for financial news PR advertising. does not undertake to update any of the information on the editorial or Site or continue to post information about any companies. The information contained herein is not intended to be used as the basis for investment decisions and should not be considered investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security., members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations, or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy, or that any security is suitable for any investor. provides this publication. Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax, and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy, or timelessness of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure, and Terms of Use, please visit

Medical Cannabis is Driving Market Expansion

Cannabis Calendar